HEADER HYDROLASE/INHIBITOR 31-DEC-18 6J2B TITLE CTX-M-64 BETA-LACTAMASE S130T SULBACTAM COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-LACTAMASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 29-291; COMPND 5 EC: 3.5.2.6; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 GENE: BLACTX-M-64; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI 'BL21-GOLD(DE3)PLYSS AG'; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 866768 KEYWDS BETA-LACTAMASE INHIBITOR COMPLEX, HYDROLASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Q.CHENG,S.CHEN REVDAT 3 22-NOV-23 6J2B 1 REMARK REVDAT 2 13-MAY-20 6J2B 1 AUTHOR JRNL REVDAT 1 30-OCT-19 6J2B 0 JRNL AUTH Q.CHENG,C.XU,J.CHAI,R.ZHANG,E.WAI CHI CHAN,S.CHEN JRNL TITL STRUCTURAL INSIGHT INTO THE MECHANISM OF INHIBITOR JRNL TITL 2 RESISTANCE IN CTX-M-199, A CTX-M-64 VARIANT CARRYING THE JRNL TITL 3 S130T SUBSTITUTION. JRNL REF ACS INFECT DIS. V. 6 577 2020 JRNL REFN ESSN 2373-8227 JRNL PMID 31709791 JRNL DOI 10.1021/ACSINFECDIS.9B00345 REMARK 2 REMARK 2 RESOLUTION. 1.44 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0189 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.44 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.54 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 72642 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.154 REMARK 3 R VALUE (WORKING SET) : 0.153 REMARK 3 FREE R VALUE : 0.187 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3797 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.44 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.48 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5214 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.76 REMARK 3 BIN R VALUE (WORKING SET) : 0.2000 REMARK 3 BIN FREE R VALUE SET COUNT : 260 REMARK 3 BIN FREE R VALUE : 0.2270 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3898 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 451 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.59 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.064 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.068 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.042 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.070 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.973 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.960 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4030 ; 0.023 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3833 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5472 ; 2.380 ; 1.977 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8881 ; 1.246 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 522 ; 6.857 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 164 ;39.473 ;24.512 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 675 ;11.926 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 31 ;12.644 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 646 ; 0.171 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4485 ; 0.016 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 746 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2088 ; 1.740 ; 1.649 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2087 ; 1.733 ; 1.647 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2604 ; 2.410 ; 2.473 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2605 ; 2.413 ; 2.475 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1942 ; 2.888 ; 1.968 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1942 ; 2.887 ; 1.968 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2867 ; 4.192 ; 2.842 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4605 ; 5.122 ;21.432 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4529 ; 5.066 ;21.056 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6J2B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 16-JAN-19. REMARK 100 THE DEPOSITION ID IS D_1300010343. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-APR-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97917 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 93345 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.310 REMARK 200 RESOLUTION RANGE LOW (A) : 46.540 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.0 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.31 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.34 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5TWD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 31.69 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES, PH7.4, 25% PEG10000, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 52.94000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 1 REMARK 465 HIS A 2 REMARK 465 HIS A 3 REMARK 465 HIS A 4 REMARK 465 HIS A 5 REMARK 465 HIS A 6 REMARK 465 SER A 7 REMARK 465 SER A 8 REMARK 465 GLY A 9 REMARK 465 LEU A 10 REMARK 465 VAL A 11 REMARK 465 PRO A 12 REMARK 465 ARG A 13 REMARK 465 GLY A 14 REMARK 465 SER A 15 REMARK 465 HIS A 16 REMARK 465 MET A 17 REMARK 465 ALA A 18 REMARK 465 SER A 19 REMARK 465 GLY A 20 REMARK 465 GLY A 21 REMARK 465 THR A 22 REMARK 465 GLU A 23 REMARK 465 LEU A 24 REMARK 465 GLN A 25 REMARK 465 THR A 26 REMARK 465 LEU A 289 REMARK 465 HIS B 1 REMARK 465 HIS B 2 REMARK 465 HIS B 3 REMARK 465 HIS B 4 REMARK 465 HIS B 5 REMARK 465 HIS B 6 REMARK 465 SER B 7 REMARK 465 SER B 8 REMARK 465 GLY B 9 REMARK 465 LEU B 10 REMARK 465 VAL B 11 REMARK 465 PRO B 12 REMARK 465 ARG B 13 REMARK 465 GLY B 14 REMARK 465 SER B 15 REMARK 465 HIS B 16 REMARK 465 MET B 17 REMARK 465 ALA B 18 REMARK 465 SER B 19 REMARK 465 GLY B 20 REMARK 465 GLY B 21 REMARK 465 THR B 22 REMARK 465 GLU B 23 REMARK 465 LEU B 24 REMARK 465 GLN B 25 REMARK 465 THR B 26 REMARK 465 LEU B 289 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 70 C7 TSL A 301 1.29 REMARK 500 OG SER B 70 C7 TSL B 301 1.30 REMARK 500 OG SER A 70 O8 TSL A 301 1.90 REMARK 500 OG SER B 70 O8 TSL B 301 1.98 REMARK 500 OE1 GLU B 201 NH2 ARG B 204 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 222 CG - CD - NE ANGL. DEV. = -17.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 69 -135.59 45.85 REMARK 500 GLN A 89 5.46 83.83 REMARK 500 ASN A 106 58.86 -140.51 REMARK 500 SER A 220 -125.37 -103.95 REMARK 500 CYS B 69 -137.53 46.47 REMARK 500 ASN B 106 57.36 -140.18 REMARK 500 ASP B 131 104.93 -51.56 REMARK 500 SER B 220 -126.96 -101.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN B 104 TYR B 105 -34.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue TSL A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide TSL B 301 and SER B REMARK 800 70 DBREF 6J2B A 25 289 UNP C8CP57 C8CP57_ECOLX 29 291 DBREF 6J2B B 25 289 UNP C8CP57 C8CP57_ECOLX 29 291 SEQADV 6J2B HIS A 1 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B HIS A 2 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B HIS A 3 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B HIS A 4 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B HIS A 5 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B HIS A 6 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B SER A 7 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B SER A 8 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B GLY A 9 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B LEU A 10 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B VAL A 11 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B PRO A 12 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B ARG A 13 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B GLY A 14 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B SER A 15 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B HIS A 16 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B MET A 17 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B ALA A 18 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B SER A 19 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B GLY A 20 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B GLY A 21 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B THR A 22 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B GLU A 23 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B LEU A 24 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B THR A 130 UNP C8CP57 SER 133 ENGINEERED MUTATION SEQADV 6J2B HIS B 1 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B HIS B 2 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B HIS B 3 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B HIS B 4 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B HIS B 5 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B HIS B 6 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B SER B 7 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B SER B 8 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B GLY B 9 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B LEU B 10 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B VAL B 11 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B PRO B 12 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B ARG B 13 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B GLY B 14 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B SER B 15 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B HIS B 16 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B MET B 17 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B ALA B 18 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B SER B 19 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B GLY B 20 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B GLY B 21 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B THR B 22 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B GLU B 23 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B LEU B 24 UNP C8CP57 EXPRESSION TAG SEQADV 6J2B THR B 130 UNP C8CP57 SER 133 ENGINEERED MUTATION SEQRES 1 A 287 HIS HIS HIS HIS HIS HIS SER SER GLY LEU VAL PRO ARG SEQRES 2 A 287 GLY SER HIS MET ALA SER GLY GLY THR GLU LEU GLN THR SEQRES 3 A 287 ALA ASP VAL GLN GLN LYS LEU ALA GLU LEU GLU ARG GLN SEQRES 4 A 287 SER GLY GLY ARG LEU GLY VAL ALA LEU ILE ASN THR ALA SEQRES 5 A 287 ASP ASN SER GLN ILE LEU TYR ARG ALA ASP GLU ARG PHE SEQRES 6 A 287 PRO MET CYS SER THR SER LYS VAL MET ALA ALA ALA ALA SEQRES 7 A 287 VAL LEU LYS GLN SER GLU THR GLN LYS GLN LEU LEU ASN SEQRES 8 A 287 GLN PRO VAL GLU ILE LYS PRO ALA ASP LEU VAL ASN TYR SEQRES 9 A 287 ASN PRO ILE ALA GLU LYS HIS VAL ASN GLY THR MET THR SEQRES 10 A 287 LEU ALA GLU LEU SER ALA ALA ALA LEU GLN TYR THR ASP SEQRES 11 A 287 ASN THR ALA MET ASN LYS LEU ILE ALA GLN LEU GLY GLY SEQRES 12 A 287 PRO GLY GLY VAL THR ALA PHE ALA ARG ALA ILE GLY ASP SEQRES 13 A 287 GLU THR PHE ARG LEU ASP ARG THR GLU PRO THR LEU ASN SEQRES 14 A 287 THR ALA ILE PRO GLY ASP PRO ARG ASP THR THR THR PRO SEQRES 15 A 287 ARG ALA MET ALA GLN THR LEU ARG GLN LEU THR LEU GLY SEQRES 16 A 287 HIS ALA LEU GLY GLU THR GLN ARG ALA GLN LEU VAL THR SEQRES 17 A 287 TRP LEU LYS GLY ASN THR THR GLY ALA ALA SER ILE ARG SEQRES 18 A 287 ALA GLY LEU PRO ALA SER TRP VAL VAL GLY ASP LYS THR SEQRES 19 A 287 GLY SER GLY GLY TYR GLY THR THR ASN ASP ILE ALA VAL SEQRES 20 A 287 ILE TRP PRO LYS ASP ARG ALA PRO LEU ILE LEU VAL THR SEQRES 21 A 287 TYR PHE THR GLN PRO GLN PRO LYS ALA GLU SER ARG ARG SEQRES 22 A 287 ASP VAL LEU ALA SER ALA ALA LYS ILE VAL THR ASP GLY SEQRES 23 A 287 LEU SEQRES 1 B 287 HIS HIS HIS HIS HIS HIS SER SER GLY LEU VAL PRO ARG SEQRES 2 B 287 GLY SER HIS MET ALA SER GLY GLY THR GLU LEU GLN THR SEQRES 3 B 287 ALA ASP VAL GLN GLN LYS LEU ALA GLU LEU GLU ARG GLN SEQRES 4 B 287 SER GLY GLY ARG LEU GLY VAL ALA LEU ILE ASN THR ALA SEQRES 5 B 287 ASP ASN SER GLN ILE LEU TYR ARG ALA ASP GLU ARG PHE SEQRES 6 B 287 PRO MET CYS SER THR SER LYS VAL MET ALA ALA ALA ALA SEQRES 7 B 287 VAL LEU LYS GLN SER GLU THR GLN LYS GLN LEU LEU ASN SEQRES 8 B 287 GLN PRO VAL GLU ILE LYS PRO ALA ASP LEU VAL ASN TYR SEQRES 9 B 287 ASN PRO ILE ALA GLU LYS HIS VAL ASN GLY THR MET THR SEQRES 10 B 287 LEU ALA GLU LEU SER ALA ALA ALA LEU GLN TYR THR ASP SEQRES 11 B 287 ASN THR ALA MET ASN LYS LEU ILE ALA GLN LEU GLY GLY SEQRES 12 B 287 PRO GLY GLY VAL THR ALA PHE ALA ARG ALA ILE GLY ASP SEQRES 13 B 287 GLU THR PHE ARG LEU ASP ARG THR GLU PRO THR LEU ASN SEQRES 14 B 287 THR ALA ILE PRO GLY ASP PRO ARG ASP THR THR THR PRO SEQRES 15 B 287 ARG ALA MET ALA GLN THR LEU ARG GLN LEU THR LEU GLY SEQRES 16 B 287 HIS ALA LEU GLY GLU THR GLN ARG ALA GLN LEU VAL THR SEQRES 17 B 287 TRP LEU LYS GLY ASN THR THR GLY ALA ALA SER ILE ARG SEQRES 18 B 287 ALA GLY LEU PRO ALA SER TRP VAL VAL GLY ASP LYS THR SEQRES 19 B 287 GLY SER GLY GLY TYR GLY THR THR ASN ASP ILE ALA VAL SEQRES 20 B 287 ILE TRP PRO LYS ASP ARG ALA PRO LEU ILE LEU VAL THR SEQRES 21 B 287 TYR PHE THR GLN PRO GLN PRO LYS ALA GLU SER ARG ARG SEQRES 22 B 287 ASP VAL LEU ALA SER ALA ALA LYS ILE VAL THR ASP GLY SEQRES 23 B 287 LEU HET TSL A 301 15 HET GOL A 302 6 HET TSL B 301 15 HET GOL B 302 6 HETNAM TSL TRANS-ENAMINE INTERMEDIATE OF SULBACTAM HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 TSL 2(C8 H13 N O5 S) FORMUL 4 GOL 2(C3 H8 O3) FORMUL 7 HOH *451(H2 O) HELIX 1 AA1 ALA A 27 GLN A 39 1 13 HELIX 2 AA2 CYS A 69 THR A 71 5 3 HELIX 3 AA3 SER A 72 GLU A 85 1 14 HELIX 4 AA4 GLN A 89 ASN A 92 5 4 HELIX 5 AA5 LYS A 98 LEU A 102 5 5 HELIX 6 AA6 ILE A 108 VAL A 113 5 6 HELIX 7 AA7 LEU A 119 TYR A 129 1 11 HELIX 8 AA8 ASP A 131 LEU A 142 1 12 HELIX 9 AA9 GLY A 144 ILE A 155 1 12 HELIX 10 AB1 PRO A 167 THR A 171 5 5 HELIX 11 AB2 THR A 182 LEU A 195 1 14 HELIX 12 AB3 GLY A 200 GLY A 213 1 14 HELIX 13 AB4 SER A 220 LEU A 225 5 6 HELIX 14 AB5 ARG A 274 GLY A 288 1 15 HELIX 15 AB6 ASP B 28 GLY B 41 1 14 HELIX 16 AB7 CYS B 69 THR B 71 5 3 HELIX 17 AB8 SER B 72 GLU B 85 1 14 HELIX 18 AB9 GLN B 89 ASN B 92 5 4 HELIX 19 AC1 LYS B 98 LEU B 102 5 5 HELIX 20 AC2 ILE B 108 VAL B 113 5 6 HELIX 21 AC3 LEU B 119 TYR B 129 1 11 HELIX 22 AC4 ASP B 131 LEU B 142 1 12 HELIX 23 AC5 GLY B 144 ILE B 155 1 12 HELIX 24 AC6 PRO B 167 THR B 171 5 5 HELIX 25 AC7 THR B 182 LEU B 195 1 14 HELIX 26 AC8 GLY B 200 GLY B 213 1 14 HELIX 27 AC9 SER B 220 LEU B 225 5 6 HELIX 28 AD1 GLY B 240 GLY B 242 5 3 HELIX 29 AD2 ARG B 274 ASP B 287 1 14 SHEET 1 AA1 5 GLN A 56 TYR A 60 0 SHEET 2 AA1 5 ARG A 43 ASN A 50 -1 N VAL A 46 O TYR A 60 SHEET 3 AA1 5 LEU A 258 THR A 265 -1 O THR A 265 N ARG A 43 SHEET 4 AA1 5 THR A 243 TRP A 251 -1 N ILE A 250 O LEU A 258 SHEET 5 AA1 5 VAL A 230 GLY A 238 -1 N VAL A 230 O TRP A 251 SHEET 1 AA2 2 PHE A 66 PRO A 67 0 SHEET 2 AA2 2 THR A 180 THR A 181 -1 O THR A 181 N PHE A 66 SHEET 1 AA3 2 PRO A 94 ILE A 97 0 SHEET 2 AA3 2 GLY A 115 THR A 118 -1 O GLY A 115 N ILE A 97 SHEET 1 AA4 5 GLN B 56 TYR B 60 0 SHEET 2 AA4 5 ARG B 43 ASN B 50 -1 N VAL B 46 O TYR B 60 SHEET 3 AA4 5 LEU B 258 THR B 265 -1 O TYR B 263 N GLY B 45 SHEET 4 AA4 5 THR B 244 TRP B 251 -1 N ILE B 250 O LEU B 258 SHEET 5 AA4 5 VAL B 230 SER B 237 -1 N VAL B 230 O TRP B 251 SHEET 1 AA5 2 PHE B 66 PRO B 67 0 SHEET 2 AA5 2 THR B 180 THR B 181 -1 O THR B 181 N PHE B 66 SHEET 1 AA6 2 PRO B 94 ILE B 97 0 SHEET 2 AA6 2 GLY B 115 THR B 118 -1 O GLY B 115 N ILE B 97 CISPEP 1 ASN A 104 TYR A 105 0 -25.57 CISPEP 2 GLU A 166 PRO A 167 0 17.93 CISPEP 3 GLU B 166 PRO B 167 0 10.98 SITE 1 AC1 14 SER A 70 ASN A 104 TYR A 105 ASN A 132 SITE 2 AC1 14 PRO A 167 ASN A 170 GLY A 236 SER A 237 SITE 3 AC1 14 GLY A 238 GOL A 302 HOH A 405 HOH A 414 SITE 4 AC1 14 HOH A 418 HOH A 433 SITE 1 AC2 10 SER A 70 LYS A 73 TYR A 129 THR A 130 SITE 2 AC2 10 LYS A 234 THR A 235 GLY A 236 SER A 237 SITE 3 AC2 10 TSL A 301 HOH A 414 SITE 1 AC3 10 SER B 70 LYS B 73 TYR B 129 THR B 130 SITE 2 AC3 10 LYS B 234 THR B 235 GLY B 236 SER B 237 SITE 3 AC3 10 TSL B 301 HOH B 406 SITE 1 AC4 20 MET B 68 CYS B 69 THR B 71 SER B 72 SITE 2 AC4 20 LYS B 73 ASN B 104 TYR B 105 ASN B 132 SITE 3 AC4 20 PRO B 167 ASN B 170 LYS B 234 THR B 235 SITE 4 AC4 20 GLY B 236 SER B 237 GLY B 238 GOL B 302 SITE 5 AC4 20 HOH B 402 HOH B 406 HOH B 411 HOH B 541 CRYST1 44.840 105.880 47.440 90.00 101.16 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022302 0.000000 0.004400 0.00000 SCALE2 0.000000 0.009445 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021486 0.00000